Researchers grew nasal tissue in a lab to unlock clues about how your body battles the common cold.

Investigators studied expression of type I interferons, key pathogenic drivers in systemic lupus erythematosus and lupus nephritis.

When a rhinovirus, the most frequent cause of the common cold, infects the lining of our nasal passages, our cells work ...

A new study shows the intricacies of the cold virus and how it interacts with nasal airway cells, revealing why some people ...

A new study shows that the body’s early immune response, not the virus itself, often determines how severe a rhinovirus cold ...

Cold severity hinges on nasal immune timing, with fast interferon release stopping rhinovirus early and delayed responses allowing widespread infection and symptoms.

Treatment of COVID-19 with interferon beta-1b — even for just a few days, a much shorter period than is commonly used for maintenance in multiple sclerosis (MS), for example — is associated with ...

Interferon therapies are well established as treatment options for some types of cancer, but they have not been used to treat cancers characterized by the overproduction of blood cells. The FDA has ...

During a bout of influenza, B cells interact with other immune cells and then take different paths to defend the body. One path is the B cells that differentiate into lung-resident memory B cells, or ...